1Department of Surgery, School of Medicine, Keio University, Tokyo, Japan.
Artificial red cells and platelets are being developed to address blood shortages and transfusion risks. Hemoglobin vesicles show promise as oxygen carriers, while platelet substitutes aim to improve bleeding control.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: